🇺🇸 FDA
Pipeline program

Placebo solution for IV infusion, ARGX-117, HUMAN NORMAL IMMUNOGLOBULIN (IV), Placebo solution for IV infusion, HUMAN NORMAL IMMUNOGLOBULIN (IV)

ARGX-117-2302

Phase 3 small_molecule active

Quick answer

Placebo solution for IV infusion, ARGX-117, HUMAN NORMAL IMMUNOGLOBULIN (IV), Placebo solution for IV infusion, HUMAN NORMAL IMMUNOGLOBULIN (IV) for Multifocal Motor Neuropathy is a Phase 3 program (small_molecule) at Argenx with 1 ClinicalTrials.gov record(s).

Program details

Company
Argenx
Indication
Multifocal Motor Neuropathy
Phase
Phase 3
Modality
small_molecule
Status
active

Clinical trials